SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " guardian " 587 found 🔀 AI-powered Shuffle
Guardians' playoff push includes moves to strengthen rotation and offense
The Cleveland Guardians have made three trades to bolster their lineup and surprisingly their rotation as they seek a third consecutive AL Central title
Guardians' Foster Griffin: Dealt to Cleveland
Guardians' Foster Griffin: Dealt to Cleveland
Three Positives From the Week of July 26th
This year’s trade deadline is an exciting time for the Guardians.
If Not AOC, Then Who?
What do we do if Alexandria Ocasio-Cortez decides not to run for president in 2028? It makes sense that many leftists are currently focused on calling on her to take the plunge. But the absence of a Plan B, or even much discussion about one, is worrisome. The US Left can’t afford to sit out the 2028 Democratic primary. Doing so in 2024 was a disaster: our abstention self-marginalized anti-billionaire politics from the national conversation and thereby gave space for Harris to pivot to the “center” (i.e. the policy preferences of corporate donors, establishment hacks, and AIPAC). Abstaining again in 2028 would be especially counterproductive since democratic socialists now have so much wind in our sails after our big electoral wins in NYC and across the country. It’s time to deepen our momentum, organization, and profile — not to retreat to the margins during America’s single most important political battle. Even more urgently, keeping Trump’s heir out of the White House may depend on whether leftists and the party’s unprecedentedly disenchanted base can force the Democrats in 2028 to take meaningful steps towards a very angry electorate and away from the corporate-consultant blob that has helped get us into this mess. If AOC (or Abdul El-Sayed) decides to run, we should enthusiastically go all in — DSA, fighting unions, progressive organizations, anybody who wants to see a better country and world. But, as far as I can tell from the outside, there’s a real chance that she doesn’t run. And we can’t just wait and see where she lands before discussing alternatives, since AOC’s decision might not come for quite a while, giving us little time to scramble at the last minute for an alternative. So we should start working now on getting a Plan B into motion, and recruiting a good candidate for the role. Here’s one idea. A Worker Candidate — Healthcare Not Warfare 2028 Run a union worker Leftists don’t need to always run experienced, well-known socialist politicians for high-profile contests. Lula, the current president of Brazil, began his political career as a metalworker militant who ran for governor of São Paulo in 1982. Especially in an era of institutional distrust, it’s possible to lean hard into making a virtue out of a working-class comrade’s distance from traditional politics. Experience abroad shows this clearly. Rachel Kéké — an immigrant hotel housekeeper — ran as the candidate of the leftist La France Insoumise for the National Assembly in 2022, defeating a former minister in the Macron government. The Belgian Workers’ Party in 2024 won its first Flemish seat in the European Parliament by running Rudi Kennes, a three-decade veteran of the Opel Antwerp auto factory. And the South Korean left in 2024 elected auto factory militant Yoon Jong-oh to the National Assembly. If a tiny French Trotskyist organization could make such a big splash in 2002 and 2007 by running a well-spoken postal worker cadre for office — the LCR’s Olivier Besancenot received about 1.5 million first-round votes — it’s not far-fetched to expect that a much larger organization like DSA, together with a broader coalition of the willing, could run this playbook to much greater effect. This is especially the case now that almost everything DSA does immediately becomes a national news story. We don’t need someone famous. We just need a charismatic, well-vetted comrade who works in a relatable working-class occupation — e.g. a nurse, or a worker in auto or construction, or at Amazon. Ideally, they have a compelling personal story or have been part of a significant strike or organizing campaign, but even those criteria don’t necessarily have to be deal-breakers. The main lesson of the Graham Platner fiasco isn’t that we should never run outsiders for office (the momentum he generated proves the exact opposite), but that they need proper vetting and roots in democratic membership organizations like DSA or a union. In any case, there are plenty of ways to signal working-class authenticity without resorting to Platner’s or Fetterman’s performative macho white dude affect. Better to have someone of any gender or race who is actually working class, with firm socialist politics, who can speak from experience about the day-to-day realities of trying to make it in America. There are surely at least a dozen such worker leaders in our movement nationwide; we just need to sit down and convince one that their personal sacrifice for the greater good (i.e. running for president) will be worth it. If we don’t have a frontrunner with a clear path to victory like AOC (or El-Sayed, were he to win Michigan), it’s better to embrace someone whose decision to run in itself tells an important story about US politics: workers have been iced out of our political system and are now fighting hard to break back in. The novelty factor, in itself, would generate press. And it would help democratic socialists signal to the American public that our movement’s defining characteristic is that we represent workers vs. bosses, not that we’re “the furthest left” force in American politics — a framework that suggests we’re extremists and that helps our opponents isolate us from non-college-educated voters by highlighting extremely minoritarian (and misguided) stances included in DSA’s platform like prison abolition. We don’t get many opportunities to speak to tens of millions of Americans; we need to use these opportunities to broaden our appeal beyond those already in our orbit. Run to polarize the 2028 primary and general election around “Medicare for All” and “End All Aid to Israel” Why should democratic socialists use our scarce time and volunteer energy to run in a race we’re unlikely to win? Running in the 2028 primary will not only recruit us scores of members (imagine having a DSA member intervening in eleven nationally televised primary debates!), but — more importantly — it has the potential to be a decisive leap forward towards an America that finally starts meeting the needs of working people instead of HMO and AIPAC billionaire donors. Polarizing litmus tests are good, actually — as long as they’re fought for around popular demands in a thoughtful and strategic way. Democratic socialists have an opportunity and responsibility to make the 2028 primary about two of the most widely and deeply felt issues of our moment: domestically, America’s unaffordable, family-breaking private healthcare system; internationally, America’s bankrolling of the genocidal Israeli government. A candidacy relentlessly demanding Medicare for All and No Aid to Israel would pose a sharp question to the American public, the Democratic Party, and other 2028 contenders: Why can’t working-class Americans afford their healthcare bills at the same time that our government is spending at least $3.8 billion yearly to fund an Israeli regime eager to keep dragging us and the world into more forever wars? Our candidate can agitate around a clear message: I’m running to give voice to all those working-class Americans who are struggling to get by. No matter what state you live in, who you voted for in 2024, or your background, it’s just plain common sense that we should make healthcare more affordable instead of spending billions to enable the Israeli government’s crimes against humanity. Every American who agrees with me when I say ‘Medicare for All — Not a Dime for Israel’ should make their voice heard through our campaign. Racking up a high number of votes for this agenda is a crucial way to show the Democratic Party and the country as a whole that we can’t keep supporting a life-destroying status quo in our healthcare system and in the Middle East. If we want to defeat Trump’s handpicked crony this coming November, we need to speak to ordinary people’s frustrations with the status quo — we can’t keep running the same tired establishment playbook and expecting a different result. For those highly engaged voters (or skeptical media pundits) who raise concerns about wasting votes, the candidate can take the time to explain why this isn’t the case: It's true I'm a long shot. But Zohran showed anything can happen — and voting for me is a pragmatic decision, not a wasted vote. In a heavily divided primary with a large number of candidates and a very discredited establishment, my campaign and the democratic socialist movement I’m part of are positioned to be the balance of power if we can get a large enough number of voters to loudly demand Healthcare Not Warfare. Since there’s a high chance no candidate will get to 50% in the 2028 primaries, the Democrats could very well be heading towards a brokered convention, where a disciplined, principled current committed to breaking from corporate donors can play an outsized role in making sure whoever ends up with the nomination raises the banner of single-payer healthcare and cutting aid to Israel. How exactly could running this sort of primary campaign be translated into actual leverage? The candidate replies: I’m aiming to win the nomination, but if I don’t achieve that goal, my delegates and I will pledge our support in the primary only for a candidate who agrees in the general election to call for ending US aid to Israel and establishing Medicare for All at home. These are both winning planks for November against the Republicans, and the only reason I can see that other candidates haven’t yet raised these is that they’re still more scared of the donor class than they are of the people. That needs to change. If Democratic leaders want young people, workers, and those sick of the status quo to show up in big numbers this November, they need to meet us halfway. In this way, whether or not we win the nomination, democratic socialists could still play a decisive role in 2028. The approach outlined here is similar to what radical left parties periodically do in parliamentary democracies like Denmark or Sweden when they find themselves as a junior partner electorally: they dictate to center-left allies what their terms would be for enabling, from the outside, the formation of a new government. Running a Healthcare Not Warfare candidate will make it significantly more likely that the 2028 Democratic candidate stands with ordinary people instead of donors on these two pivotal planks — a shift that will, in turn, make it easier to achieve the existentially important task of defeating MAGA’s heir in November. Look at how much popular traction the Uncommitted movement got with a similar strategy in 2024 with so little on-the-ground organization — surely we can go much further with a working-class candidate, a much bigger DSA, and a Democratic Party base that has turned against Israel, billionaires, and the hacks in the party who prop them up. Objections and Responses There are quite a few objections to this proposal, many of which are very reasonable. Let me briefly address each here. Socialists shouldn’t waste their scarce time and resources on a candidate unlikely to win. This is a good rule in general, but there are important exceptions, and presidential elections are the main one. There’s no other political contest that gets anything like this level of attention and engagement in the US, so if you want to be a serious force in nationwide politics, you basically can’t afford not to have a candidate. Far from being an overall drain on our resources, running a dynamic 2028 campaign would likely result in a major net increase in members and capacity. In that spirit, the very pragmatic Milwaukee sewer socialists — who mostly ran to win at home in Wisconsin — supported Eugene Debs’s propagandistic presidential campaigns, which they correctly saw as a crucial means of recruiting to the Socialist Party. And now that the (post-1972) Democratic Party gives more weight to voters than party operatives in determining its presidential nomination, it’s become feasible to run as a socialist in primaries without risking a split in the vote against the Republicans in November. We should just support Ro Khanna, who also supports M4A and ending aid to Israel. I like Ro Khanna and would enthusiastically vote and canvass for him for president were he to get the nomination. But there’s a real chance that Khanna’s bid for office doesn’t catch on; he lacks the grassroots organizational apparatus of DSA, and, because he’s not really of the Left or labor (despite his current very good positions), he’s unlikely to generate the type of buy-in and enthusiasm that a DSA candidate would. Moreover, Khanna would be running as an individual, not as someone emerging from and building an organized movement — his campaign would not likely focus on building sustained power from below, nor would it likely polarize the 2028 primary around M4A and Israel aid. Also, and not inconsequentially, the poor electoral results for Tom Steyer and Saikat Chakrabarti this spring suggest that there’s perhaps not much of a popular appetite in the Democrats’ base to support multi-millionaire class traitors. Much better, then, to run a democratic socialist worker. If by Super Tuesday it’s clear that our campaign has captured the main left lane in the primary, Khanna should drop out and endorse us; conversely, if he’s managed to capture this lane, DSA could at that point transform its Healthcare Not Warfare campaign into an independent campaign to elect Ro Khanna focused on winning (and holding him accountable to) those two critical planks. An openness to consolidating an anti-corporate candidate by Super Tuesday is a necessary component of the strategy I’m proposing, because otherwise we risk splitting the primary votes (per DNC rules, you need at least 15% to get any delegates to convention). We should convince Shawn Fain or Sara Nelson to run for president instead. I agree it’d be great if either ran for president, but my impression is that there’s basically no chance that will happen in 2028, because both are firmly focused on their union leadership duties (and, in the case of Fain, beating back a federal witch-hunt). This plan could have DSA end up endorsing a non-socialist, non-DSAer for president. That’s against our principles. It’s a myth, and bad politics, that socialists can’t ever support candidates who aren’t members of their organization and/or who don’t call themselves socialists. Bernie, after all, was not a DSAer. And socialists abroad regularly make tactical decisions about if and when supporting a non-socialist candidate makes sense from the standpoint of promoting working-class interests, defending democracy, and building a socialist current in the process. If your “principles” prevent you and DSA from helping achieve the momentous stride forward of having a Democratic candidate in 2028 run on Medicare for All and ending aid to Israel, those “principles” are not very good. In fact, they actively undermine the causes they’re aiming to support. We shouldn’t confuse principles (working-class independence) with tactics (the best way to advance this in a given context). In my recent article in Catalyst on Milwaukee sewer socialism (I’ve uploaded the full text here), I have a section showing how similarly rigid rules about endorsements had to be eventually discarded in the old Socialist Party nationwide after WWI because they tended to lead socialists towards a sectarian abstention from broader anti-corporate electoral insurgencies beyond their party’s control. For what it’s worth, Lenin’s current under Tsarism frequently backed bourgeois candidates in the second round of elections and Lenin himself advocated that British Communists support Labour Party candidates; for his part, Kautsky in 1912 defended the German Social Democracy’s electoral pact with the Progressives in the runoffs. If our predecessors could be that tactically flexible in an era before the limits of their underlying strategic assumptions about intransigent class politics in capitalist democracies were made clear, then there’s no need to insist on being more tactically rigid today, after a century’s worth of accumulated experience. As long as you maintain your own political profile and organization while engaging in broader coalitional efforts, there’s zero inherent contradiction with the principle of political independence. More specifically: DSA and allied organizations should enthusiastically back Michigan’s Abdul El-Sayed if AOC declines to run and he throws his hat in the presidential ring. (I have no idea whether he’s even considering this path, but there’ll surely be chatter about it if he wins his Senate race this November.) Though he doesn’t call himself a socialist, El-Sayed is a principled Berniecrat, a consistent fighter for Palestine, and would have a clear path to victory. Using the “s” word is far less important than whether a campaign fights for the interests of working people at home and abroad — and whether actively participating in it can grow the organized working class and the Left. And the same holds true if a less anti-corporate candidate were, under pressure, to adopt our two Healthcare Not Warfare planks. Why focus only on M4A and ending US aid to Israel? There are so many other important issues to fight for! Obviously there are many pivotal issues beyond healthcare and Israel, and our candidate — and especially our organizations involved in the campaign — should be prepared to speak on all of these. But one of the crucial lessons of the Zohran campaign is that you have to relentlessly stay on message if you want to cut through the noise. CNN and Fox News will want to talk about DSA’s views on Venezuela and abolishing the police; we need to polarize the debate on the widely and deeply felt issues that are most favorable for growing the Left, isolating our opponents, and winning urgently needed changes. One recent poll found 63% of Americans support M4A, even after respondents were told it would raise taxes and eliminate most private insurance. Another found that 74% of Democrats opposed “providing additional economic and military support to Israel.” And focusing on two demands sets the campaign up to be able to leverage its mandate to make clear demands upon other candidates (which we can’t do if we run with a laundry list of demands). Talking about a Plan B is a distraction from the more urgent work of building a groundswell of calls on AOC to run. It’s good for DSAers, fightback unionists, and progressive organizations to try to convince AOC to run. This proposal is meant as an addendum to pushes to get AOC to run and to line DSA up for that eventuality, not as a substitute for those efforts. But I’m worried that, like in 2024, we might eventually find ourselves with no time to find a viable alternative unless we start now. DSA, with its abundant deliberative processes, moves slowly. The approach you’re suggesting seems risky. If a DSA candidate runs but doesn’t receive a lot of votes, it’ll undercut our current national momentum. This is a reasonable worry. All big initiatives always carry risks, and the path I’m advocating is certainly not free of these. That said, if a Healthcare Not Warfare campaign doesn’t catch on like we envisioned, it’s a pretty simple pivot in March 2028 to explain that in the future we really need our standard-bearers like AOC, or our growing bench of national electeds, to step up in presidential primaries. Moreover, it’s worth noting that the risk of my Plan B proposal is on the whole significantly less than the risk entailed by an AOC run. We should all back her if she runs, since she’d fire up the base, provide huge openings for organizing, have a real shot at defeating a Republican (especially given MAGA’s unpopularity), be a great standard-bearer for our issues, particularly M4A and ending aid to Israel, and be less willing than mainstream candidates to capitulate to any anti-democratic machinations from Trump and co. But it’s also true that AOC could lose, which would be a devastating setback to the country and the Left. Or she could win and find herself unable to pass much, if any, of her (and our) program, a demoralizing prospect. So if we’re willing to take these risks with AOC (and we should), it follows that we should be able to take lower-level risks if she doesn’t throw her hat in the ring. What’s Your Plan B? The US Left is facing its biggest opening for growth and influence since the 1930s. Initiatives that would have been impossible a few months ago are now potentially feasible. A President AOC is now easier to imagine, but if she ultimately assesses that the risks aren’t worth the potential reward in 2028, we can’t be left flat-footed. So even if you’re not convinced by the specifics of my Plan B, I hope you can at least agree that it’d be a disaster for us not to have one — and not to start getting a Plan B into motion. Hopefully other organizers and political currents will put forward their responses and alternative ideas ASAP. The stakes are too high to just wait and see. More As always, please share this article widely. This newsletter depends on all you lovely people to get the word out. Thank you! I uploaded the full text of my Catalyst article on Milwaukee sewer socialism here (it’s updated and 3x as long as the version published earlier on this substack). If you haven’t yet, please make sure to subscribe to Catalyst here; I read every issue front to back, highly recommend. 🌹🎵 Ivan Lins (arranged by Arthur Verocai) — “General da Banda” 🌹🎵
Changeable Guardian ESTIQUE for PS5, Xbox Series, Switch, and PC launches August 6
AMATA Games will release Cat Hui Trading LLC-developed side-scrolling robot shoot ’em up Changeable Guardian ESTIQUE for PlayStation 5, Xbox Series, Switch, and PC via Steam and Microsoft Sto…
Diamondbacks vs Guardians Highlights ⚾️ MLB on FOX
Watch the best highlights between the Arizona Diamondbacks and the Cleveland Guardians.
Panama: Haemophilus influenzae meningitis case reported in Veraguas Health Region
The Veraguas Health Region, located in the central-western region of Panama, confirmed a case of meningitis caused by the Haemophilus influenzae bacteria in a 12-year-old student from La Primavera School, diagnosed on July 29. The patient remains hospitalized, is receiving appropriate treatment, and is in stable clinical condition. The regional health director of Veraguas, Xavier A. Torres Domínguez, reported that, once the diagnosis was confirmed, the Ministry of Health (Minsa), in coordination with the Social Security Fund (CSS), immediately activated the epidemiological investigation and health response protocols established for this type of event. Canada: Haemophilus influenzae type B outbreak in Calgary As part of the actions implemented, the Epidemiology teams carried out the identification and monitoring of the patient’s close contacts, applying the corresponding preventive measures to reduce the risk of transmission and safeguard the health of the educational community. Health authorities explained that meningitis caused by Haemophilus influenzae is a bacterial disease that requires timely medical attention. In that regard, they urged the population to immediately seek medical attention if they experience symptoms such as high fever, severe headache, stiff neck, vomiting, drowsiness, or altered mental status. They also reiterated that vaccination is the main preventive measure against this disease, and therefore called on parents and guardians to verify that their children’s immunization schedules are complete, in accordance with the Expanded Program on Immunization (EPI). Outbreak News Today is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe
Ultra-processed food companies hindering health drives by suing countries, says WHO
Exclusive: Director general accuses corporations of obstructing efforts to tackle obesity crisis after investigation by Guardian and others
ECB official warns climate crisis poses growing threat to ‘core financial stability’
Exclusive: As wildfires rage across Europe, Frank Elderson tells the Guardian nature loss poses a growing risk to the global economy
D-backs @ Guardians Discussion
Today’s Lineups DIAMONDBACKS GUARDIANS Corbin Carroll – RF Angel Martinez – RF Geraldo Perdomo – SS Jose Ramirez – 3B Gabriel Moreno – C Chase DeLauter – DH Ketel Marte – 2B Rhys Hoskins – 1B Max Kepler – LF Brayan Rocchio – SS Nolan Arenado – 3B David Fry – LF Adrian Del Castillo […]
The Guardian view on the Lovell telescope: budget cuts to physics are bad science and worse politics
Editorial: Funders have picked a damaging fight with scientists and the public. They should reconsider their plans
I’ve seen what can confound Farage on his home turf: optimism. People need a politics that offers them that
You can’t blame his constituents in Clacton for their pessimism – because they have been let down for years, says Guardian columnist Owen Jones
Chase Burns leads Reds into doubleheader vs. Guardians
It’s a Tuesday full of Ohio Cup baseball!
The Guardian view on Europe’s wildfires: politics must catch up with the new reality
Editorial: At a time when the quickening pace of global heating has never been clearer, climate policies are being deprioritised
Should the Guardians Sell at the Trade Deadline?
Facing some hard truths
Offense Lifeless As Guardians Lose Again
This game was one of the tougher watches I’ve had this season. The offense was beyond lifeless as they mustered just 5 hits with 8 strikeouts to 1 walk. This offense is not really capable of surviving Chase DeLauter rest days right now. The 1-2-3 of Kwan, Ramirez, Bazzana had 4 combined hits, the rest […]
Chicago White Sox Release Brother of Braves’ Player Jurickson Profar
The Chicago White Sox currently sit atop the AL Central with a 54-48 record. They lead the Guardians by 1.5 games in the division. An Atlanta Braves player who is a little bit forgotten is Jurickson Profar. Profar signed a three-year, $42 million deal with the Braves a couple of seasons ago, but he is […] The post Chicago White Sox Release Brother of Braves’ Player Jurickson Profar appeared first on HEAVY.
Guardians News: Every Town Has Its Ups and Downs
News and Notes for Saturday, July 25th, 2026
Jose Ramirez Makes Immediate Impact in Return, Despite Guardians' Loss
The Cleveland Guardians may have lost to the Minnesota Twins, but it was a win to see Jose Ramirez back on the field.
TWINS AT GUARDIANS: Cecconi vs. Ober, discussion
Let's win a series
Sports and politics: No longer strange bedfellows
Sports has always billed itself as above petty indifferences, something that brings people together on the sanctity of the playing field. FIFA, the guardian of the soccer World Cup pledges to ensure accessibility to everyone, promising that each athlete will receive a reception that is “safe, welc...
Twins All-Star Joe Ryan surrenders 6 home runs in start vs. Guardians, the AL's worst home-run hitting team
Darline Graham’s Political Views Largely Unknown As She Launches Senate Campaign
Lindsey Graham became his sister’s legal guardian after their parents died when she was 13.
Why has Britain’s oldest political magazine become such a rabid cheerleader for Islamophobia?
A report on the Spectator’s coverage of Muslims makes for grim reading. Conservatism is now focused on this minority to the exclusion of everything else, says Guardian columnist Nesrine Malik
Pittsburgh Pirates vs. Cleveland Guardians: Jared Jones vs. Gavin Williams
The Pirates are on the road looking to grab a win today.
Ann Widdecombe’s death should make Britain ask itself: what sort of political culture do we want?
Dehumanising politicians is the first step towards justifying their elimination. It matters more than ever to keep putting the person back into the picture, says Guardian columnist Gaby Hinsliff
World Cup reader Q&A: post your questions for Guardian sports reporter Nick Ames now
After 102 games we know that 2026 World Cup final will be between Spain and Argentina in New Jersey on Sunday. Our football correspondant Nick Ames has been in the US and Mexico all tournament – post your questions for him now
Indonesia's New Capital Is Changing the Borneo Rainforest Forever. Science is Listening to the Change
Indonesia is building a new capital city in the heart of Borneo to replace sinking Jakarta. As construction transforms one of the world's most biodiverse rainforests, scientists and their indigenous collaborators are racing to record the sounds of the forest—and preserve generations of ecological knowledge before it's lost.
Fall sports updates and information
The fall sports season will be here before we know it! Here are some key summer details for students and families as we look forward to the coming season. Registration begins: High school football (grades 9-12): July 17 All other high school fall sports (grades 9-12): July 24 Modified football (grades 7-8): July 27 All other modified fall sports (grades 7-8): July 31 Please register via Final Forms. Sports physicals: All student-athletes interested in trying out for a fall sport must have an up-to-date physical submitted to Final Forms in advance of the first day of tryouts and practices. Families are encouraged to get a completed physical from their child's physician. If you are unable to get a physical from your child's physician, you can schedule a physical with Whitney Young's school-based health center by calling (518) 573-2556. Appointments will be available at Albany High School in room 4253 during July on the following dates: Thursday, July 16 between 8:30 a.m. and 12:30 p.m. Tuesday, July 21 between 8:30 a.m. and 4:30 p.m. Tuesday, July 28 between 8:30 a.m. and 4:30 p.m. Thursday, July 30 between 8:30 a.m. and 4:30 p.m. Again, you must call (518) 573-2556 to schedule your appointment and receive instructions. Whitney Young does require paperwork that must be filled out by the child's parent or guardian in order for them to be seen by the provider. Tryouts & practices begin: High school football (grades 9-12): Aug. 17 All other high school fall sports (grades 9-12): Aug. 24 Modified football (grades 7-8): Aug. 27 All other modified fall sports (grades 7-8): Aug. 31 High school student-athletes are encouraged to take part in our open gym sessions during July and August in preparation for the fall sports season. Stay tuned for fall practice schedules and competition schedules, which will be posted on our Athletics page! If you have additional questions, please contact the Athletics Department at (518) 475-6310. Let's go Falcons!
Guardians News: Three Positives From the Week of July 5th
As we reach the halfway point of the season, the Guards sit in first place.
Darline Graham Nordone: Lindsey Graham’s sister and interim US senator
Nordone was 13 when brother became her legal guardian – and was a key presence as he rose in the Republican ranks
Lindsey Graham Was Once Named the 'Guardian of Small Business.' These Are the Defining Moments of His Legacy
The senator helped shape policies that lowered corporate tax rates, playing a key role in the wider business landscape.
Nigel Farage is just one strand in the tangle of rightwing politicians and crypto investors
These financiers want to remodel the UK into a form that suits them – one that could threaten to erode the barriers between crime and business, says Guardian columnist John Harris
Los Angeles Air Force Base Kicks off Sports Day 2026
On July 1, 2026, Members of Los Angeles Air Force Base came together for the highly anticipated annual sports day. The event brought together Airmen, Guardians, and contractors, drawing them away from their daily operations to unite under a shared goal. This friendly competition not only promoted health and wellness but also fostered camaraderie outside the traditional workplace environment.
Guardians News: On to Minnesota
News and Notes for Tuesday, July 7th, 2026
Half of Americans struggle to afford groceries and gas, exclusive poll finds
About 57% of polled Americans also believe economy is worsening in grim portrait of cost of living crisis, according to Harris survey for the Guardian
Northern Trust sells $1.2B guardianship business to Wintrust
The deal boosts Wintrust’s assets under management in its wealth management business by $1.2 billion.
Guardians Lose 3-1 To White Sox
This was a pretty underwhelming game from the offense. They faced a good pitcher in Burke, but boy did they make him look great. A solo HR from Hedgey in the 5th is the only thing that kept this one from being a shutout. Hedges is now hitting .281 with a .756 OPS on the […]
Elon Musk posted twice as often on UK race and immigration as about SpaceX in IPO run-up
Guardian analysis of X feed shows how keen world’s richest person was to air his views and ‘interfere’ in British politics
Americans disgusted at Trump earning $1bn from crypto as president: ‘Obviously a grift’
Hundreds of Guardian readers expressed concerns over greed in the White House and a billionaire president unconcerned with high gas and grocery prices
The Guardian view on xenophobic violence in South Africa: anti-migrant politics can’t fix domestic problems
Editorial: Foreigners are not to blame for unemployment, crime and the state of public services. Leaders should have the courage to say so more clearly
They say Andy Burnham is ‘good at politics’ – but the proof will only come in time
The PM-in-waiting brings the promise of likability and a mission voters can believe in. He’ll need all that and more to survive, says Guardian columnist Zoe Williams
Brand New The Blood of Dawnwalker Gameplay Showcases Coen’s Investigation Skills and a Boss Battle Against the Eerie Forgotten Guardian
See Coen's investigation and fighting skills on full display in this quest gameplay from The Blood of Dawnwalker.
Cleveland Guardians’ Rookie Kahlil Watson Flashing Major League Tools
Cleveland Guardians rookie outfielder Kahlil Watson has shown power, speed, a good hit tool, and solid defense after his graduation to the major league club
Guardians rookie Cooper Ingle tosses ball into stands early after losing outs count in loss to Rangers: 'I feel terrible'
The Guardians 2026 Trade Deadline Manifesto
Surveying the landscape a month ahead of the deadline
Ahead of the MLB trade deadline, here’s where the Guardians stand
The Guardians are among the best teams in a weak American League. This is the time for them to capitalize on their situation.
'Nobody likes you': Argument between former teammates Josh Naylor and Austin Hedges gets personal in Mariners-Guardians
Cleveland Takes Series from Seattle in Sunday Victory
Seattle Mariners 5 - Cleveland Guardians 6
Guardians score, lineups vs Seattle Mariners at Progressive FIeld
The short-handed Guardians look to find some offense against the Mariners at Progressive Field. Follow along here for live updates.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Stubborn, arrogant, a genius: France’s De Gaulle epic shows up the tepidity of our politics
The man who led Free France during Nazi occupation was single-minded to the point of obstinacy. But he believed in his own power to make history, says Guardian Europe writer Alexander Hurst
Latest Injury Update on Guardians' Chase DeLauter
Chase DeLauter's return to the Cleveland Guardians' lineup might come sooner rather than later.
Keir Starmer has quit as prime minister – what will happen next in UK politics?
Britain will soon have its fifth prime minister in four years. The Guardian explains how we got here and what challenges await Starmer’s successor
Guardians' Joey Cantillo: Leans on curveball
Guardians' Joey Cantillo: Leans on curveball
Astros vs Guardians Game Discussion: 6/19/2026
Game Info Game Date/Time: Friday, June 19, 7:10 p.m. CT Location: Daikin Park, Houston, TX TV: Space City Home Network Radio: KBME 790 AM & 94.5 FM HD2; TUDN 102.9 FM HD2 (Spanish)
Tired with Iran, Trump refocuses on Ukraine
Jenna Amatulli speaks to the Guardian’s Andrew Roth about the chances this peace deal will succeed, and why Trump is turning his attention back to Ukraine
Brewers drop series finale to Guardians, 4-2
Bullpen squanders lead as offense fails to come through with big hit late
Guardian Resilience Teams promote holistic health, culture of fitness
Central to U.S. Space efforts are a transition from traditional fitness models to Holistic Health Approach, an integrated and preventative approach that prioritizes the enduring health, performance and resilience of Guardians.
Brewers Make Long Awaited Call-Up
After signing a massive pre-debut contract, elite prospect Cooper Pratt heads to Milwaukee to bolster the Brewers' lineup with speed and defense against the surging Cleveland Guardians.
The Relic: First Guardian launches July 31 for PS5 and PC, later this summer for Xbox Series and Switch 2
Dark fantasy Soulslike action RPG The Relic: First Guardian will launch for PlayStation 5 and PC via Steam on July 31, followed by Xbox Series and Switch 2l later this summer, publisher Perp Games …
Detroit Tigers series finale rained out vs Cleveland Guardians
The Detroit Tigers' game Sunday, June 14, against the Cleveland Guardians was postponed due to weather, pushing Casey Mize's return from the IL back.
Who will the Guardians be without José Ramírez?
Hello darkness my old friend
Guardians Make Chase DeLauter Announcement After Leaving Tigers Game
The Cleveland Guardians announced an update on rookie outfielder Chase DeLauter.
Tarik Skubal pitches 4 2/3 innings during first Tigers start since elbow surgery, hits 99.9 mph in loss to Guardians
Detroit turned to Skubal for the first time since April 29, and, 38 days after his 'Skubal scope' procedure, he showed some encouraging signs.
Guardians smother Tigers in Tarik Skubal’s return
Skubal looked healthy, but Daniel Schneemann’s two-run homer was the difference.
Anna Faris credits podcast with helping her through Chris Pratt divorce
Anna Faris credited a surprising project with helping her through her 2017 divorce from Chris Pratt.
AIPAC Wants Democrats to Back Israel. Instead, They’re Turning on AIPAC.
Once the guardian of the bipartisan pro-Israel consensus, it is now a polarizing force in the party.
New York Yankees @ Cleveland Guardians: Carlos Rodón vs. Parker Messick
It’s a southpaw showdown as the Yankees go for the sweep.
Michael Meadowcroft obituary
Liberal politician, local councillor and Leeds West MP who turned to journalism, writing for the Times and the Guardian
There are no guardrails now on the right of UK politics: where Restore Britain goes, others will follow
In the UK – and across the west - incendiary language and white supremacist policies are entering the political mainstream, says Guardian columnist Owen Jones
New York Yankees @ Cleveland Guardians: Gerrit Cole vs. Slade Cecconi
The Yankees’ ace looks to bounce back against the team that handed him his first loss in 627 days.
Bellinger plays hero as Yankees outlast Guardians in 10 innings
Paul Goldschmidt homered early, Ryan McMahon stayed hot, and Cody Bellinger delivered the decisive blow as the Yankees survived a tense 10-inning affair.
Rangers' Jacob deGrom: Blanks Guardians across six innings
Rangers' Jacob deGrom: Blanks Guardians across six innings
Rangers Crush Guardians to Win Series
The Texas Rangers returned the favor against the Cleveland Guardians after a rough game on Saturday.
Guardians' Brayan Rocchio: Clouts homer in win
Guardians' Brayan Rocchio: Clouts homer in win
Confessions of political liveblogger: ‘I enjoy it professionally – but, as a citizen, you can think the country’s going to hell in a handcart’
Andrew Sparrow has been writing the Guardian’s daily political live blog for more 15 years. How does he cope with the relentless psychodrama of British politics?
Guardians Dominate Rangers Behind Bibee’s Gem
The offense came alive tonight but the story of the game was Tanner Bibee’s phenomenal outing. He tossed 8 scoreless innings and had only 87 pitches, I really wish they would’ve game him a chance to complete the Maddux. He lowered his ERA all the way down to 4.09 from this outing. If Bibee can […]
Why the Rangers Were Shut Out
The Texas Rangers did not have an answer against the Cleveland Guardians on Saturday night.
Rangers host the Guardians on 4-game home win streak
The Texas Rangers host the Cleveland Guardians trying to continue a four-game home winning streak
Leaked WhatsApps, embarrassing emails: it’s bad for British politics that privacy is now dead
The principle underlying the release of the Mandelson papers is that officials are always ‘on the record’ – but our leaders must be able to speak their minds freely, says Guardian columnist Simon Jenkins
Game 63 Game Day Thread – Cleveland Guardians @ Texas Rangers
Welcome back, the top two hitters in the lineup
Upstate county's lawmakers push bill holding parents accountable
The bill would require parents or guardians of juvenile offenders to complete mandatory parenting classes. Those who refuse would face community service.